29 March 1991
COMMERCIAL ITEM DESCRIPTION
OXAZEPAM CAPSULES, USP
The General Services Administration has authorized the use of this Commercial Item Description as a replacement for Military Specification MIL-O-37773 which is cancelled.
Shall be Oxazepam Capsules, USP
Shall be in accordance with the requirements of the USP.
All ingredients shall be of pharmaceutical grade.
1. 10 mg
2. 15 mg
3. 30 mg
The capsules shall assay to contain the labeled amount of Oxazepam per capsule within the applicable assay limits for the tablets.
The capsules shall be considered by the FDA to be therapeutically equivalent with Oxazepam Capsules, USP, by Wyeth Laboratories at the same dosage and administration schedule.
Each capsule shall be marked/embossed with a product identification code to identify the active ingredients(s), strength, and manufacturer. The materials used in marking/embossing the dosage forms shall be acceptable to the FDA. The actual code used for the product shall be left to the discretion of the supplier
Workmanship. The capsules shall be free from defects which detract from their appearance or impair their serviceability.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business